AMARILLO, TX -- (MARKET WIRE) -- February 12, 2007 -- Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) today announced that the publication of data on the use of oral interferon for influenza is now available online in the Biochemical & Biophysical Research Communications (BBRC). These data indicate that oral interferon is life saving to treated mice given an otherwise fatal infection. These mice data are important because the mouse model is used by government laboratories to evaluate antivirals for testing in humans. The principal author of the online article in BBRC is Dr. Manfred Beilharz, Head, Microbiology and Immunology, School of Biomedical, Bimolecular and Chemical Sciences, M502, The University of Western Australia, Western Australia, 6009.
